Pharmaceutical composition comprising guttiferone F for the treatment of prostate cancer
    1.
    发明授权
    Pharmaceutical composition comprising guttiferone F for the treatment of prostate cancer 有权
    包含用于治疗前列腺癌的葡聚糖F的药物组合物

    公开(公告)号:US09408811B2

    公开(公告)日:2016-08-09

    申请号:US14333524

    申请日:2014-07-17

    摘要: Prostate cancer is the most commonly diagnosed cancer in males and one of the leading causes of cancer death. Although treatment options have increased for some patients, overall progress has been modest. Thus, there is a great need to develop new treatments. This invention relates to a method for treating cancer comprising using an anti-cancer compound of formula (I): More particularly, it relates to said anti-prostate cancer compound that can be isolated from Garcinia esculenta or chemically synthesized and its specific anticancer/antitumor activity. The invention has a specific application in treating human prostate cancer.

    摘要翻译: 前列腺癌是男性最常诊断的癌症,也是导致癌症死亡的主要原因之一。 虽然一些患者的治疗方案有所增加,但总体进展情况不大。 因此,非常需要开发新的治疗方法。 本发明涉及一种治疗癌症的方法,包括使用式(I)的抗癌化合物:更具体地说,涉及可从藤黄enta或化学合成的抗前列腺癌化合物及其特异性抗癌/抗肿瘤 活动。 本发明在治疗人类前列腺癌方面具有特殊应用。